Bank Julius Baer & Co’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.92M Sell
22,276
-2,571
-10% -$641K 0.01% 234
2025
Q4
$6.03M Sell
24,847
-5,422
-18% -$1.39M 0.02% 220
2025
Q3
$8.29M Buy
30,269
+8,425
+39% +$2.3M 0.02% 207
2025
Q2
$5.64M Buy
21,844
+20,127
+1,172% +$4.8M 0.02% 235
2025
Q1
$384K Buy
1,717
+657
+62% +$153K ﹤0.01% 389
2024
Q4
$267K Buy
+1,060
New +$255K ﹤0.01% 400
2023
Q4
Sell
-961
Closed -$142K 567
2023
Q3
$142K Sell
961
-60
-6% -$10.8K ﹤0.01% 402
2023
Q2
$223K Sell
1,021
-689
-40% -$154K ﹤0.01% 399
2023
Q1
$374K Sell
1,710
-437
-20% -$94.8K ﹤0.01% 377
2022
Q4
$447K Buy
2,147
+164
+8% +$36K ﹤0.01% 352
2022
Q3
$433K Buy
1,983
+1,313
+196% +$299K ﹤0.01% 344
2022
Q2
$140K Sell
670
-5
-0.7% -$1.06K ﹤0.01% 452
2022
Q1
$164K Buy
675
+5
+0.7% +$1.21K ﹤0.01% 441
2021
Q4
$175K Hold
670
﹤0.01% 538
2021
Q3
$177K Buy
670
+1
+0.1% +$273 ﹤0.01% 556
2021
Q2
$165K Sell
669
-1,967
-75% -$414K ﹤0.01% 593
2021
Q1
$511K Buy
2,636
+1,968
+295% +$395K ﹤0.01% 442
2020
Q4
$142K Sell
668
-322
-33% -$64.2K ﹤0.01% 603
2020
Q3
$170K Hold
990
﹤0.01% 531
2020
Q2
$190K Sell
990
-2,288
-70% -$374K ﹤0.01% 473
2020
Q1
$483K Buy
+3,278
New +$522K 0.01% 316

Other funds holding RMD

Bank Julius Baer & Co's RMD Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its ResMed (RMD) stake by 10% in Q1 2026, selling an estimated $641K and leaving 22,276 shares worth $4.92M. The position accounts for 0.01% of the portfolio, ranked #234.

Bank Julius Baer & Co first reported a position in RMD in Q1 2020 and has held it in 21 quarters since. The position peaked at $8.29M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Bank Julius Baer & Co held 22,276 shares of ResMed worth $4.92M as of Q1 2026.
  • Bank Julius Baer & Co sold 2,571 ResMed shares in Q1 2026, an estimated $641K.
  • ResMed made up 0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #234 holding.
  • Bank Julius Baer & Co first reported a position in ResMed in Q1 2020 and has held it in 21 quarters since.
  • Bank Julius Baer & Co's ResMed position peaked at $8.29M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.